Financial Performance - The company's revenue for Q1 2024 was CNY 359,316,221.44, representing a decrease of 3.28% compared to the same period last year[4] - Net profit attributable to shareholders was CNY 13,737,901.17, an increase of 1.99% year-on-year[4] - The net profit after deducting non-recurring gains and losses was CNY 11,827,437.33, which is a 13.16% increase compared to the previous year[4] - Total operating revenue for Q1 2024 was ¥359,316,221.44, a decrease of 3.1% from ¥371,485,658.61 in Q1 2023[19] - Net profit for Q1 2024 was ¥11,804,500.85, slightly up from ¥11,636,531.02 in Q1 2023, representing an increase of 1.4%[20] - The company’s total comprehensive income for Q1 2024 was ¥11,804,500.85, compared to ¥11,636,531.02 in Q1 2023, reflecting a slight increase[20] - The net profit for Q1 2024 reached CNY 19,514,630.48, representing an increase of 16.1% from CNY 16,808,210.00 in Q1 2023[28] Research and Development - Research and development expenses totaled CNY 19,264,381.61, accounting for 5.36% of revenue, an increase of 1.14 percentage points[5] - Research and development expenses increased to ¥19,264,381.61 in Q1 2024, up 22.5% from ¥15,669,388.94 in Q1 2023[19] - Research and development expenses increased to CNY 10,577,976.47 in Q1 2024, up from CNY 8,676,505.05 in Q1 2023, indicating a focus on innovation[27] Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,440,391,490.20, a decrease of 2.00% from the end of the previous year[5] - As of March 31, 2024, the company's total assets amounted to RMB 2,440,391,490.20, a decrease from RMB 2,490,206,974.45 at the end of 2023[16] - Total liabilities decreased to ¥877,203,673.50 in Q1 2024 from ¥907,854,318.70 in Q1 2023, a reduction of 3.9%[18] - Total liabilities decreased to ¥744,267,153.54 in Q1 2024 from ¥779,607,616.17 in Q1 2023, reflecting a reduction of approximately 4.5%[26] - The total liabilities and shareholders' equity amounted to CNY 2,284,557,943.87, a slight decrease from CNY 2,330,996,620.68 in the previous year[27] Cash Flow - Cash flow from operating activities was CNY 38,457,270.07, with no applicable year-on-year comparison[4] - Operating cash flow for Q1 2024 was ¥38,457,270.07, a significant improvement from -¥46,025,592.56 in Q1 2023[22] - Total cash inflow from operating activities increased to ¥367,537,445.65 in Q1 2024, compared to ¥333,361,900.53 in Q1 2023, reflecting a growth of approximately 10.2%[22] - Cash outflow from operating activities decreased to ¥329,080,175.58 in Q1 2024 from ¥379,387,493.09 in Q1 2023, indicating a reduction of about 13.3%[22] - The cash flow from operating activities generated a net amount of CNY 45,816,331.03, a significant improvement compared to a net outflow of CNY 28,233,160.93 in Q1 2023[29] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 4,813[12] - The company reported a total of 3,210,305 shares held in the repurchase special securities account, which is not included in the top 10 shareholders[15] - The top shareholder, Beijing Ruishibang Fine Chemical Technology Co., Ltd., holds 5,907,500 shares, accounting for 4.84% of total shares[15] - The company has engaged in securities lending, with 81,000 shares lent out, representing 0.07% of total shares[15] Future Outlook - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[31] - The earnings per share for Q1 2024 is expected to improve as the company focuses on enhancing profitability and operational efficiency[31]

证券代码：688350 证券简称：富淼科技 公告编号：2024-042 转债代码：118029 转债简称：富淼转债 江苏富淼科技股份有限公司 关于召开 2023 年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 会议召开时间：2024 年 05 月 10 日(星期五) 下午 14:00-15:00 ● 会议召开地点：上海证券交易所上证路演中心（网址： http://roadshow.sseinfo.com/） ● 会议召开方式：上证路演中心网络互动 ● 投资者可于 2024 年 04 月 30 日(星期二)至 05 月 09 日(星期四)16:00 前登 录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 IR@feymer.com 进行提问。公司将在说明会上对投资者普遍关注的问题进行回答。 江苏富淼科技股份有限公司（以下简称"公司"）已于 2024 年 4 月 3 日发布 公司 2023 年年度报告，为便于广大投资者更全面深入地了解公司 2023 年度经营 成果、财务状况， ...

上 海 证 券 交 易 所 上市公司董事、监事、高级管理人员在 6 个月内买入公司股票 又将其卖出的行为，构成短线交易。根据《中华人民共和国证券法》 （以下简称《证券法》）第四十四条的规定，涉及短线交易情形时， 董事、监事、高级管理人员、自然人股东持有的股票或者其他具有 股权性质的证券，包括其配偶、父母、子女持有的股票或者其他具 1 有股权性质的证券。公司时任董事配偶在 6 个月内买入又卖出其所 持公司股份的行为，构成短线交易。 当事人： 吴邦元，江苏富淼科技股份有限公司时任董事。 2024 年 3 月 30 日，江苏富淼科技股份有限公司（以下简称公司） 披露《关于董事亲属短线交易及致歉的公告》，时任董事吴邦元之 配偶缪某芳于 2023 年 5 月 4 日至 2024 年 3 月 18 日期间买卖公司股 票，合计买入 58,714 股,买入金额 878,476.9 元，卖出 49,514 股， 卖出金额 798,546.24 元。上述行为构成短线交易，涉及股数为 49,514 股，累计收益 77,694.78 元已全部上缴公司。缪某芳承诺， 自最后一笔买入公司股票之日起六个月内不卖出公司股票，若未来 违规出售 ...

证券代码：688350 证券简称：富淼科技 公告编号：2024-041 转债代码：118029 转债简称：富淼转债 江苏富淼科技股份有限公司 关于"富淼转债"预计满足转股价格修正条件的提示 性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任 重要内容提示： 根据中国证券监督管理委员会核发的《关于同意江苏富淼科技股份有限公司 向不特定对象发行可转债注册的批复》（证监许可[2022]2757 号），公司向不特 定对象发行可转债 450.00 万张，每张面值为人民币 100 元，本次发行募集资金 总额为 45,000.00 万元。经上海证券交易所自律监管决定书（[2023]2 号）文同 意，公司 45,000.00 万元可转换公司债券已于 2023 年 1 月 9 日起在上海证券交 易所挂牌交易，债券简称"富淼转债"，债券代码"118029"。 （二）可转债转股期限 根据有关规定和《江苏富淼科技股份有限公司向不特定对象发行可转换公司 债券证券募集书》（以下简称"《募集说明书》"）的约定，公司本次发行的"富淼 转债"自 2023 ...

| 证券代码：688350 | 证券简称：富淼科技 | 公告编号：2024-040 | | --- | --- | --- | | 转债代码: 118029 | 转债简称: 富淼转债 | | 江苏富淼科技股份有限公司 2023 年年度股东大会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次会议是否有被否决议案：无 一、 会议召开和出席情况 （一） 股东大会召开的时间：2024 年 4 月 24 日 （二） 股东大会召开的地点：江苏省张家港市凤凰镇江苏富淼科技股份有限公 司行政区 公司三楼会议室 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 4 | | --- | --- | | 普通股股东人数 | 4 | | 2、出席会议的股东所持有的表决权数量 | 65,350,763 | | 普通股股东所持有表决权数量 | 65,350,763 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比 | 54 ...

富淼科技年度股东大会 法律意见书 一、关于本次股东大会的召集、召开程序 1.本次股东大会的召集 本次股东大会由公司董事会召集。公司于2024年4月2日召开了第五届董事会 第十七次会议，会议决定于2024年4月24日召开2023年年度股东大会。 江苏世纪同仁律师事务所 关于江苏富淼科技股份有限公司 2023 年 年度股东大会的法律意见书 致：江苏富淼科技股份有限公司 根据《中华人民共和国公司法》《中华人民共和国证券法》《上市公司股东 大会规则》等法律、法规和规范性文件以及《江苏富淼科技股份有限公司章程》 （以下简称"《公司章程》"）的规定，本所接受公司董事会的委托，指派本所 律师出席公司2023年年度股东大会，并就本次股东大会的召集、召开程序、出席 会议人员资格、召集人资格、表决程序以及表决结果的合法有效性出具法律意见。 为出具本法律意见书，本所律师对本次股东大会所涉及的有关事项进行了审 查，查阅了相关会议文件，并对有关问题进行了必要的核查和验证。 本所律师同意将本法律意见书随公司本次股东大会决议一并公告，并依法对 本法律意见书承担相应的责任。 本所律师根据相关法律、法规和规范性文件的要求，按照律师行业公认的业 ...

证券代码：688350 证券简称：富淼科技 转债代码：118029 转债简称：富淼转债 江苏富淼科技股份有限公司 2023 年年度股东大会会议资料 2024 年 4 月 江苏富淼科技股份有限公司 2023 年年度股东大会会议资料 目 录 | 2023 | | | 年年度股东大会会议须知 | | 3 | | --- | --- | --- | --- | --- | --- | | 2023 | | | 年年度股东大会会议议程 | | 5 | | 议案一：关于公司 | 2023 | | 年年度董事会工作报告的议案 | 7 | | | 议案二：关于公司 | 2023 | | 年年度监事会工作报告的议案 | 14 | | | 议案三：关于公司 | 2023 | | 年年度财务决算报告的议案 | 20 | | | 议案四：关于公司 | 2023 | | 年年度报告及其摘要的议案 | 27 | | | 议案五：关于公司 | 2023 | | 年年度利润分配方案的议案 | 28 | | | 议案六：关于公司董事 | | 2023 | 年度薪酬发放情况及 | 2024 年度薪酬方案的议案 30 | | | 议案七：关于公司 ...

一、保荐机构和保荐代表人发现的问题及整改情况 无 华泰联合证券有限责任公司 关于江苏富淼科技股份有限公司 2023 年度持续督导跟踪报告 | 保荐机构名称：华泰联合证券有限责任公司 | 被保荐公司名称：江苏富淼科技股份有限公 | | --- | --- | | | 司 | | 保荐代表人姓名：蔡福祥 | 联系电话：0512-85883377 | | 保荐代表人姓名：刘森 | 联系电话：0512-85883377 | 根据《证券法》《证券发行上市保荐业务管理办法》和《上海证券交易所科 创板股票上市规则》等有关法律、法规的规定，华泰联合证券有限责任公司（以 下简称"华泰联合证券"或"保荐机构"）作为江苏富淼科技股份有限公司（以下简 称"富淼科技"、"公司"或"发行人"）首次公开发行股票并在科创板上市项目、向 不特定对象发行可转换公司债券并在科创板上市项目的保荐机构，对富淼科技进 行持续督导，并出具本持续督导跟踪报告： 公司面临的风险因素主要如下： （二）核心竞争力风险 （一）业绩大幅下滑或亏损的风险 1、宏观经济及下游行业波动导致公司业绩下滑的风险 公司的营业收入主要来源于水溶性高分子和功能性单体产品，下游客户主 ...

证券代码：688350 证券简称：富淼科技 江苏富淼科技股份有限公司 投资者关系活动记录表 编号：2024-001 特定对象调研 □分析师会议 投资者关系活动类 □媒体采访 □业绩说明会 别 □新闻发布会 □路演活动 □现场参观 □其他 （请文字说明其他活动内容） 华泰证券 方翔羽 新华日报基金 杨诚 参与单位名称及人 个人投资者 张利东 员姓名 个人投资者 李鹏 个人投资者 钱丽新 时间 2024年4月7日—2024年4月8日 参会方式 线上通讯和公司现场交流相结合 副总裁、财务总监兼董事会秘书 邢燕 公司接待人员姓名 证券事务代表 顾宇轩 ...

Financial Performance - The company's operating revenue for 2023 was ¥1,640,089,571.92, a decrease of 3.34% compared to the previous year[26]. - The net profit attributable to shareholders for 2023 was ¥27,207,614.93, down 78.78% year-on-year, while the net profit after deducting non-recurring gains and losses was ¥20,035,671.02, a decrease of 80.94%[29]. - The net cash flow from operating activities was ¥102,421,685.02, a reduction of 26.90% compared to the previous year[29]. - The company's total assets at the end of 2023 were ¥2,490,206,974.45, a decrease of 2.04% from the end of the previous year[27]. - The net assets attributable to shareholders increased by 0.70% to ¥1,507,942,105.53 at the end of 2023[27]. - Basic and diluted earnings per share for 2023 were both ¥0.22, reflecting a decline of 78.85% year-on-year[28]. - The company's main raw materials, including acrylonitrile and chloroprene, are highly correlated with crude oil prices, which have shown significant volatility[114][115]. - The company achieved operating revenue of RMB 1.64 billion, a decrease of 3.34% compared to the previous year[119]. - The net profit attributable to shareholders was RMB 27.21 million, down 78.78% year-on-year[119]. - Total assets at the end of the reporting period amounted to RMB 2.49 billion, a decrease of 2.04% year-on-year[119]. Dividend and Shareholder Information - The company plans to distribute a cash dividend of 2.48 RMB per 10 shares, totaling approximately 29.5 million RMB (including tax) based on a total share capital of 118,939,794 shares after deducting repurchased shares[6]. - The board of directors has approved the profit distribution plan, pending shareholder approval[7]. Operational Risks and Challenges - The company has detailed various operational risks and corresponding countermeasures in the report[5]. - The company has not achieved profitability since its listing[5]. - The company faced challenges due to a decline in sales volume of steam and hydrogen, as well as falling prices of key raw materials[26]. - The company’s operational risks include safety production risks due to the handling of hazardous materials and the potential for accidents during production[109]. - The company faces risks related to technological updates and progress, as it operates in a technology-driven industry with strong technical barriers[107]. Research and Development - The research and development expenditure accounted for 4.70% of operating revenue, a slight decrease from 4.73% in the previous year[28]. - The company has added 37 new authorized patents, including 23 invention patents and 14 utility model patents, bringing the total to 247 authorized patents by the end of the reporting period[43]. - The company has developed 21 core technologies in functional monomer manufacturing, water-soluble polymer applications, and water treatment membranes, participating in the establishment of multiple national and industry standards[80]. - The company has developed a proprietary technology for producing acrylamide with a conversion rate and purity exceeding 99.9%, resulting in high product yield and quality[81]. - The company has achieved a significant reduction in waste gas emissions, meeting national standards through advanced production techniques[81]. Market and Industry Trends - The water-soluble polymer industry is experiencing rapid growth, driven by national strategies for high-quality and green development, with a shift from import reliance to export growth[58]. - The domestic water-soluble polymer market is experiencing continuous development and structural adjustment, with a focus on integration, scale, and concentration of the industry[63]. - The company aims to enhance its competitive edge by focusing on the core industry chain of hydrophilic functional polymers, targeting sectors such as papermaking, water treatment, mineral processing, oil and gas extraction, and textile dyeing[169]. - The company is actively pursuing industrial investment and mergers and acquisitions to integrate upstream and downstream resources for growth[181]. Digital Transformation and Innovation - The company has implemented a digital transformation strategy, completing the construction and implementation of digital systems such as CRM and SRM to enhance market insight and supply chain efficiency[49]. - The company is promoting safety culture and management efficiency, implementing comprehensive safety measures and digital management systems[179]. - The company is advancing digital transformation to enhance operational efficiency and innovation capabilities, aiming for sustainable development[177]. Investment and Expansion Plans - The company signed an investment cooperation agreement to build a new project in Anhui with a total investment of approximately 2.1 billion yuan, covering an area of about 368 acres and expected to produce 445,000 tons of water-soluble polymers and functional monomers annually[45]. - The company plans to invest approximately 2.1 billion RMB in a project to build 445,000 tons of water-soluble polymers and supporting functional monomers in Anqing High-tech Zone, with a phased construction approach[152]. - The company is focusing on high-quality construction of the Anhui base to achieve industrial upgrades and capacity expansion[175]. Corporate Governance and Compliance - The company emphasizes the importance of the accuracy and completeness of the annual report, with management taking legal responsibility[4]. - The company has not reported any non-operating fund occupation by controlling shareholders or related parties[9]. - The company does not have any special arrangements for corporate governance[9]. - Strict compliance with regulatory requirements is being enforced to enhance corporate governance and internal control management[180].